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Drs. LaMont (left) and Smith examine gel that demonstrates molecular character of protein mucin, which 
has been the focus of much of their gallstone-related research. 
Gallstones: New findings 
enhance prospects for 
a non-invasive therapy 
Despite the efforts of many investigators, 
gallstones have remained largely resistant to 
medical therapies. 
One therapy, current ly used m a i n l y i n Eu-
rope, has achieved a modest degree of suc-
cess, says J. Thomas LaMont , M . D . , head of 
the Evans Section of Gastroenterology. I t i n -
volves g iv ing the patient bile salts, whose 
normal role includes dissolving cholesterol. 
But w h i l e the therapy has proven effective at 
dissolving some eholesterol gallstones, i t has 
significant drawbacks. 
"When bile-salt pi l l s are taken four times a 
day for at least t w o years," says Dr. LaMont , 
"gallstones w i l l disappear i n about half of 
the patients. But i f they don't take their 
medications fa i thfu l ly , i t w o n ' t w o r k . " 
The regimen, moreover, usually eauses 
chronic diarrhea. A n d even w h e n it 's effec-
tive, the stones typica l ly come back once the 
patient stops tak ing the medication. 
A second approach involves injecting a 
cholesterol-dissolving agent direetly in to the 
gallbladder or bile ducts. That technique w i l l 
dissolve most stones i n about three weeks, 
says Dr. LaMont . But sinee the procedure is 
invasive, and requires a long hospital stay, i t 
too is of l i m i t e d value. 
The lack of a medical therapy that is both 
effective and convenient has meant that 
most Americans w i t h symptomatic gall-
stones must undergo surgery. A n estimated 
h a l f - m i l l i o n cholecystectomies are performed 
each year. (The tota l numher of Americans 
w i t h gallstones is put at roughly 20 mi l l ion . ) 
For the past decade, however. Dr. LaMont 
and his associates have been seeking safer 
and less onerous forms of therapy. Bui lding 
on the pioneering w o r k of Donald M . Small, 
M . D . , chief of the Section of Biophysics and 
director of BUSM's Biophysics Inst i tute , 
they've i l l u m i n a t e d the biochemical events 
that underlie gallstone format ion. More re-
cently, the investigators have identif ied 
agents that are h ighly effective at dissolving 
stones in vitro. 
One starting point for the group's research 
Continued on page 2 
V O L U M E 2, N U M B E R 2 
SPRING 1986 
Inside: A look at the 
work of the scientist 




at Boston University 
Medical Gcntcr 
Gallstones... 
Continued from page 1 
was the fact that gallstones are associated 
w i t h gallbladder stasis. 
"There are a number of factors—preg-
nancy, prolonged intravenous feeding, fast-
ing, b i r th-control medications—that produce 
stasis of the gallbladder," says Dr. LaMont . 
"These cohditions are al l associated w i t h 
gallstones, and i t has been shown that stasis 
is the prob lem." 
From Dr. Small's w o r k , Dr. LaMont 's 
group was aware that supersaturation of the 
bile w i t h cholesterol is also needed i n order 
for gallstones to f o r m . But supersaturation 
alone w o n ' t cause stones. I n fact, i t is a com-
m o n condi t ion i n societies w i t h cholesterol-
r i ch diets, and seems to occur as frequently 
i n individuals w i t h o u t gallstones as i n gall-
stone sufferers. 
The investigators knew, therefore, that 
something else besides supersaturation and 
stasis was involved i n creating stones. One 
focus of their quest for answers as to what 
that something else m i g h t be was the mucus 
secreted by the gallbladder. The group was 
especially interested i n the protein muein , 
the m a i n component of mucus. 
Hypersecretion also plays a role 
I n lab experiments, the investigators 
showed that hypersecretion of m u c i n by the 
gallbladder is a necessary precursor of gall-
stones. According to Bernard F. Smith, M . D . , 
a member of the Section of Gastroenterology 
and Dr. LaMont 's associate, hypersecretion 
combined w i t h stasis produces a sharply i n -
creased risk that gallstones w i l l fo rm. 
"When the mucus is secreted in to the bile, 
i t begins to accumulate as a gel ," says Dr. 
Smith . " T h a t may have to do w i t h stasis. If 
the gallhladder was contracting avidly and 
forcing everything out, then even if you were 
secreting excessive amounts of mucus i t 
w o u l d n ' t matter, because the mucus w o u l d 
he flushed downstream. But w i t h stasis, the 
gel remains i n the gallbladder." 
A binding surface for cholesterol 
The investigators have found that the gel 
becomes l i n k e d w i t h b i l i r u b i n , a breakdown 
product of hemoglobin that gives bile its 
greenish t i n t . They aren't sure whether the 
b i l i r u b i n is necessary for gallstones to form, 
says Dr. Smith . But i n any ease, the mucus-
b i l i r u b i n combinat ion produces what is de-
scribed as a pigmented sludge. 
The sludge provides a b inding surface for 
cholesterol, and m u c i n appears to be the key 
actor i n the binding process. " M u c i n is a 
long molecule that's shaped something l ike a 
bottle brush, " says Dr. LaMont . "There's a 
protein core, and 'hristles' that are made out 
of sugars." Various points along the eore are 
free of "brist les ," he adds, and these points 
serve as b inding sites for cholesterol and b i l i -
rub in . 
The investigators don't k n o w what makes 
the soft compound harden in to gallstones. 
Ident i fying m u c i n as a key component of the 
stones, however, has aided the group i n tar-
geting its search for treatments. 
Investigating treatment options 
"From a therapeutic point of view, the key 
point about eholesterol gallstones is that 
they contain more than just cholesterol," 
says Dr. LaMont . "They have a matr ix , 
w h i c h is made out of m u c i n and probably 
some other proteins. We have to attack that 
matr ix as w e l l as the cholesterol." As a re-
sult, the group has been experimenting w i t h 
a combinat ion of t w o types of agents: a bile-
salt compound, w h i c h dissolves the choles-
terol , and an agent k n o w n as Muco-mist , 
w h i c h is used to treat mucus buildups i n 
asthmatics. Tests of the combined agents in 
vitro showed that they could dissolve gall-
stones w i t h i n t w o to three days. 
Since the agents under study are estab-
lished medications, and since both are 
k n o w n to reach the gallbladder when admin-
istered orally, the prospects for a useful ther-
apy seem promising. Dr. LaMont emphasizes, 
however, that a lot more lab w o r k must be 
done before c l inical trials can be considered. 
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Some examples of human gallstones. 
"The next step is to design a delivery sys-
tem for these agents," he notes. " W e ' l l prob-
ably start by i m p l a n t i n g h u m a n gallstones i n 
laboratory animals so we can determine the 
best way to administer the agents and dis-
solve the stones." • 
Suggested further reading 
1. Smith , B.F., L a M o n t , J.T.: Ident i f icat ion of gall-
bladder m u c i n - b i l i r u b i n complex i n h u m a n gall-
stone m a t r i x . J. C l i n . Invest. 76: 439-445, 1985. 
2. Smith , B.F., L a M o n t , J.T.: Hydrophobic b inding 
properties of bovine gallbladder m u c i n . J. Biol . 
Chem. 239: I 2 I 7 0 - I 2 I 7 7 , 1984. 
3. Smith , B.F., LaMont , I.T.: Pathogenesis of gall-
stones, Hosp. Pract. 93-104, Dec. 1984. 
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Macrophages and T-cells: 
Their interactions permit 
the precision targeting 
of immune responses 
After starting his career studying develop-
mental biology, David I . Beller, Ph.D., 
branched off in to immunology. 
The decision to change his focus, says Dr. 
Beller, w h o recently left his posi t ion as an 
assoeiate professor of pathology at Harvard to 
head the newly formed Evans Research I m -
munology U n i t , came i n 1975, when he was 
f in ishing up his doctorate at Princeton and 
deciding what to do for a "post doc." 
Immunology appealed to h i m for t w o rea-
sons, he says. I t was then beginning to 
emerge as the source of various hiological 
tools, inc luding monoclonal antibodies, that 
clearly were going to be helpful i n prohing 
basic issues i n developmental biology. I n ad-
di t i on , he saw the f ie ld as an in t r igu ing sub-
category of developmental biology. 
" I n most biological development, the sys-
t e m needs to be isolated as m u c h as possible 
f r o m the environment , " he notes. "The ner-
vous system, the musculature, the cardiovas-
cular system—they al l develop i n response to 
internal cues. The i m m u n e system is the 
only major system that develops m a i n l y i n 
response to the demands of the environ-
m e n t . " 
Dr. Beller's interest i n i m m u n o l o g y took 
h i m to Harvard, to w o r k under E m i l Unanue, 
M . D . , a professor of immunopathology. Dr. 
Unanue was interested i n macrophages, and 
transmit ted what has become a career-long 
concern w i t h these fascinating i m m u n e cells 
to Dr. Beller. 
"The macrophage is the pr imordia l i m -
mune ce l l , " notes Dr. Beller. " I f you go back 
along the evolutionary ladder, you f i n d there 
are organisms that have macrophage-like 
cells hut don't have lymphocytes or any 
other type of i m m u n o c y t e . " 
Maerophages presumably do a respectable 
job of f ight ing off microbes i n organisms l ike 
the sponges. But i n more sophisticated or-
ganisms, they must collaborate w i t h other 
types of i m m u n e cells to create an appropri-
ately sensitive and versatile defense system. 
Macrophages as 'educators' 
From early on i n his studies of the i m -
mune system, Dr. Beller was interested i n 
the interactions between macrophages and T-
lymphocytes, or T-cells. The interactions are 
numerous, and they're also reciproeal. When 
infectious bacteria, for example, enter the 
body, macrophages and T-cells play a k i n d of 
leap-frog, w i t h macrophages s t imula t ing the 
growth rate of appropriately responsive T-
cells, and these T-cells, i n t u r n , enhancing 
the baetericidal capacity of the macrophages. 
Macrophages, however, also influence T-
cells long before the lymphoeytes heeome 
major actors i n i m m u n e responses. Drs. 
Beller and Unanue discovered that macro-
phages appear to he involved i n the "educa-
Dr. Beller (rear) and Mariusz Wasile, M.D. , post-
doctoral fellow, go over data from experiment. Im-
munology Unit is located on third floor of Evans 
Building. 
t i o n " of T-cells, preparing t h e m for specific 
functions w i t h i n the i m m u n e system. 
" I n evaluating macrophages f r o m periph-
eral sites i n the body, we found that they se-
crete a factor that can st imulate T-cell ma-
t u r a t i o n , " explains Dr. Beller. "But since T-
cells mature i n the thymus—that 's w h y 
they're called T-cells—we weren't sure i t 
was the secretions f r o m peripheral sites that 
were s t imula t ing T-cell maturat ion. We felt 
i t could also be secretions f r o m maerophages 
i n the t h y m u s . " 
I n faet, further experiments demonstrated 
that macrophages are p l e n t i f u l i n the thy-
mus, suggesting strongly that the eells carry 
out their n u r t u r i n g role i n that location. 
" I f y o u t h i n k of the maturat ion of T-cells 
as being an educational process, then the 
thymus is the school and macrophages are 
members of the facul ty , " says Dr. Beller. 
A theory about T-cell proliferation 
As schools go, the thymus seems to be un-
usually rigorous. O n l y about five percent of 
stem cells emerge f r o m the thymus as ma-
ture T-cells, w i t h the remainder being de-
stroyed before they reach matur i ty . Though 
the macrophages are pr ime suspects i n the 
destruction, their role is not yet confirmed. 
Also unclear are the reasons for the high 
m o r t a l i t y rate. 
" I t may he that you need to have a lot of 
prol i ferat ion i n order to produee a T-cell pop-
ula t ion that is h ighly diverse," says Dr. 
Beller. "So m u c h growth increases the 
chanee for a rearrangement of the T-cell 
genes that code for the various surface recep-
tors the eells have, or for genetic error that 
leads to var ia t ion . " 
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Once T-cells leave the thymus, they're 
ready to be called in to action against viruses, 
bacteria, chemical insults and any other of 
the s t i m u l i that can activate the i m m u n e 
system. Macrophages also play a crucial role 
i n this subsequent phase of T-cells' lives. 
A n d one key too l w i t h w h i c h they influence 
T-cells during an i m m u n e response is the 
mediator i n t e r l e u k i n 1. 
Interieukin 1's immune roles 
" I n t e r l e u k i n I is the first mediator of T-
cell pro l i fera t ion , " says Dr. Beller. " N o r m a l 
T-cells w o n ' t grow w i t h o u t i t . There's also 
some indicat ion that in te r l euk in I is neces-
sary for B-cell growth , so you're really talk-
ing about a very basic regulatory molecule i n 
terms of T-cell and B-cell prol i ferat ion. " 
Macrophages are one of the m a i n produc-
ers of I L - I , whose immunologica l roles, i n 
addit ion to s t imula t ing T-cells, include i n -
ducing fever. (The mediator is very similar i n 
makeup to various pyrogens.) Immunologists 
have long assumed that the only way i n 
w h i c h macrophages provide the mediator to 
the i m m u n e system is by secreting i t in to 
the bloodstream. Recently, though, Dr. Beller 
and his associates discovered that I L - I also is 
expressed on the cell surface, and may be 
very active i n that setting as w e l l . 
A serendipitous discovery 
The discovery happened by accident. Dr. 
Beller had designed a hench system that per-
m i t t e d the effects of cell-surface components 
of macrophages to be distinguished f r o m the 
effects of their secreted products. 
" I felt that i n order to understand the mac-
rophages' role i n antigen presentation, and 
the way i n w h i c h antigens on the cell sur-
face are perceived by T-cells, we needed to 
study macrophages w i t h no IL-1 present," 
says Dr. Beller. "But w h e n we designed a sys-
tem to do this , we found that the macro-
phages vigorously s t imulated T-cel l growth 
w i t h o u t our adding any I L - I . " 
The start l ing finding indicated strongly 
that I L - I doesn't have to be seereted i n order 
to influence T-cells. A n d subsequent experi-
ments showed that the I L - I on the cell sur-
face may have a m u c h more potent impact, 
i n terms of macrophage/T-cell interactions. 
than the secreted suhstance. 
As Dr. Beller's group continues to explore 
the role of IL-1 on the cell surfaces, they are 
also studying the other side of the macro-
phage/T-cell interact ion: the impact of T-
cells on macrophages. 
Interferon from T-cells 
T-cells as a group are noted for the m u l t i -
p l i c i t y of roles they play. Cyto ly t i c T-cells 
can attack v i t a l l y infected cells on their 
o w n ; suppressor T-cells restrict the aggres-
siveness of other T-cells; helper T-cells boost 
the effectiveness of their fe l low i m m u n e -
system combatants. 
Photomicrograph shows T-cells (small white 
objects) attached to surface of macrophage. 
It 's the helper T-cells that act i n a " k i c k -
m e " fashion, s t imula t ing macrophages to 
produce I L - I , w h i c h i n t u r n triggers more T-
cell growth . One of the ways the T-cells ac-
complish this, says Dr. Beller, is by secreting 
interferon. 
" I t ' s a f o r m of the mediator called i m m u n e 
inter feron," he explains, "and i t appears to 
be one of the key regulators of macrophage 
act ivat ion." 
Besides boosting the abi l i ty of macro-
phages to activate T-cells, the interferon also 
increases their destructive tendencies. Inter-
feron-activated macrophages, for example, 
are very efficient at destroying tumor cells, 
whereas their inactivated counterparts are 
not. 
As research i n t o these and other hasic as-
pects of i m m u n o l o g y continue, there is a 
Continued on page 6 
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The role of the Evans Research Immunology Unit 
The Evans Research Immunology U n i t , established earlier this spring, w i l l not only pro-
vide the organizational focus for basic immunologic research but w i l l also provide research 
support to c l in ica l investigators throughout the department. 
"There is plenty of excellent research i n immunology being carried out at the School of 
M e d i c i n e , " says N o r m a n G. Levinsky, M . D . , director of the Evans, " b u t investigators at 
the School have no specific mandate to collaborate w i t h Evans investigators involved i n 
c l in ica l research. We wanted a u n i t w i t h i n the Evans that w o u l d give the department a 
nucleus of first-rate immunologists who could apply their expertise i n helping to pursue 
investigations i n a wide range of cl inical areas." 
Dr. Levinsky added that the Department is fortunate to have Dr. David I . Beller as head 
of the new U n i t . " D r . Beller is a superb scientist, w h o has done some very important w o r k 
i n cell-mediated aspects of immunology, " says Dr. Levinsky. "He's eager to w o r k w i t h 
other investigators w i t h i n the department, and many of them, I know, are delighted to 
have someone w i t h his background on board." 
Research Day: Honoring 
young investigators, 
promoting interchange 
W i t h the success of the first Evans/Univer-
sity Hospita l Research Day as a st imulus, 
the Evans and U H ' s Department of Medicine 
are gearing up for a second one this fa l l . 
The m a i n a i m of the Research Day pro-
gram, w h i c h was begun i n connection w i t h 
next year's 75th anniversary celebration for 
the Evans, is to spotlight the w o r k of 
younger researchers associated w i t h the 
Evans and the Departments of Medicine at 
Univers i ty Hospital , Boston C i t y Hospital 
and the Boston Veterans A d m i n i s t r a t i o n 
Medical Center, and to promote scientific i n -
terchange. 
" A lot of us tend to focus on what's going 
on i n our section, or our department, and we 
don't really appreciate the breadth of what 's 
going on i n other areas," says Jerome Brody, 
M . D . , head of the Evans Section of Pulmo-
nary Medicine and coordinator of the inaugu-
ral program. "Research Day was conceived as 
a way to encourage interactions among dif-
ferent sections and departments, and to focus 
at tent ion on the research heing done hy 
younger investigators." 
Judging trainees' abstracts 
For the first Research Day, held last Octo-
ber, trainees f r o m the participating depart-
ments submit ted abstracts to a committee 
made up of senior members of the D i v i s i o n 
of Medicine. From among the roughly 50 ab-
stracts submitted, the committee chose six 
winners. Their authors were then invi ted to 
give papers on their w o r k to an assemblage 
of members of the departments involved i n 
the program. 
"We had original ly planned to choose five 
abstracts for presentation," says Dr. Brody, 
" b u t the qual i ty of the w o r k was so high 
that we ended up choosing six, and we gave 
another six honorable ment ions . " 
This year's Research Day, scheduled for 
Oct. 21, is being expanded i n l ight of the 
qual i ty of last year's submissions, says J. 
Thomas LaMont , M . D . , head of the Evans 
Section of Gastroenterology and coordinator 
of the event. I n addit ion to the six trainees 
chosen to give papers, another group w i l l be 
asked to prepare poster presentations on 
their w o r k . 
Distinguished speakers take part 
Besides presentations by trainees, the pro-
grams include lectures by distinguished 
speakers. Last year's speakers were David 
Hubel , Ph.D., a Nobel laureate and professor 
of neurobiology at Harvard Medical School, 
and John M . Dietschy, M . D . , chief of gastro-
enterology at the Univers i ty of Texas Medi -
cal Center i n Houston. 
This year's speakers w i l l be Dav id Balti-
more, M . D . , a Nobel laureate w h o is a pro-
fessor of hiology at M I T and heads the af f i l i -
ated Whitehead Inst i tute ; and John Eordtran, 
M . D . , a professor of medicine at Baylor U n i -
versity i n Dallas, Texas. Dr. Eordtran, whose 
specialty is gastroenterology, also is an Evans 
graduate. 
This year's Research Day program w i l l he-
gin at 12 noon w i t h grand rounds featuring 
Dr. Eordtran and w i l l conclude w i t h Dr. 
Baltimore's ta lk . (For more on the program, 
please contact the Evans Department of 
Medicine at 617-638-7250.) 
A t the 1985 event, a reception was held i n 
BUSM's Hiebert Lounge for the inv i ted 
speakers and the authors of the top six sub-
missions. Prizes were awarded to the six, 
w i t h W i l l i a m Bishai of the Evans Section of 
Biomolecular Medicine receiving top prize. 
The w i n n i n g submissions i n the 1985 Re-
seareh Day compet i t ion were: 
W. Bishai, J. Boyd, J. M u r p h y . A genetically engi-
neered t o x i n - a M S H fusion gene shows specific 
t o x i c i t y for cul tured melanoma cells. 
W.W. Cruikshank, J.B. Fishman, D . M . Center. 
Second messengers responsible for l y m p h o k i n e -
mediated T- lymphocyte migrat ion . 
A.V. Cybulsky, H . G . Rennke, J.D. Feintzeig, D.J. 
Continued on page 6 
Authors of winning sub-
missions in 1985 Research 
Day competition gather in 
Wilkins Board Room of 
the Evans. They are, from 
left, Peter A. Dale, M . D . , 
Infectious Diseases; Wil-
liam Cruikshank, Pulmo-
nary Medicine; Caron A. 
Lyman, Infectious Dis-
eases; A n n L . Gilligan, 
Ph.D., Endocrinology and 
Metabolism; Audrey V. 
Cybulsky, M.D. , Renal; 
and William Bishai, Biom-
olecular Medicine. 
The program was be-
gun in connection 
with next year's 75th 
anniversary of the 
Evans. 
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Noteworthy 
Thomas J. Ryan, M.D. , president of the 
American Heart Association, delivered his 
presidential address at the A H A ' s annual sci-
entif ic sessions i n Washington, D.C. , last 
November. The ta lk was entit led, "Cardiol -
ogy 1985: Whi ther are We Tending and What 
Ought Our A i m to Be." Dr. Ryan, w h o heads 
the Evans Section of Cardiology, said that 
cardiologists should be aggressively promot-
ing prevention. He also said that the care of 
patients " i n the complete sense" should be a 
basic a i m of the specialty, and called for a 
continued emphasis on applying the findings 
of both basic and c l inical research i n day-to-
day practice. 
William B. Kannel, M.D. , chief of the Evans 
Section of Preventive Medicine and Epide-
miology, has been awarded an honorary Doc-
tor of Medicine degree by the Medieal Eae-
u l t y of the Univers i ty of Gotehorg i n 
Sweden. The degree was i n recognition of Dr. 
Kannel's many contributions to the under-
standing and prevention of cardiovascular 
Dr. Dietschy Dr. Hubel 
Research Day. .. 
Continued from page 5 
Salant. Complement- induced glomerular epithel ial 
cell i n j u r y : Role of the membrane attack complex 
i n rat membranous nephropathy. 
P.A. Dale, P.A. Rice. Sensit ivity and resistance 
to n o r m a l h u m a n serum of neisseria gonorrhoeae 
is s t imula ted hy isolated lipopolysaccharides i n -
serted i n t o l iposomal membranes. 
A . L . Gi l l igan , H . Kawamora, G.T. Faircloth, J.L. 
Vai tukai t i s . Di f ferent ia l subcellular d i s t r ibut ion of 
hioactive h u m a n chorionic gonadotropin i n 
pseudo-pregnant rat ovary. 
C.A. Lyman, E.R. Simons, D . M e l n i c k , R.D. Dia-
m o n d . N e u t r o p h i l respiratory burst act ivat ion 
w i t h o u t membrane depolarization s t imulated by 
unopsonized Candida albicans hyphae. • 
disease. The honoree directed the Eram-
ingham Heart Study f r o m 1966 to 1979, and 
has conducted numerous studies in to the ori -
gins of heart disease, strokes and related con-
ditions. 
The James D . Bruce M e m o r i a l A w a r d for 
contributions to preventive medicine has 
been awarded to Gene H . StoUerman, M.D. , 
chief of the Evans Section of General Inter-
nal Medicine. The award, conferred by the 
American College of Physicians, honors Dr. 
Stollerman for his w o r k i n the prevention of 
infectious disease, most notably rheumatic 
fever. That a i lment has been al l but e l i m i -
nated i n the industrial ized countries. Dr. 
Stollerman also has been named a D i s t i n -
guished Physician of the Veterans A d m i n i s -
trat ion, and w i l l supervise the development 
of a geriatrics t ra ining program at the Bed-
ford V A Medical Center. A previous recipient 
of a V A Dist inguished Physicianship was the 
late Franz J. Ingelfinger, M . D . , former chief of 
the Section of Gastroenterology. • 
Immune responses... 
Continued from page 4 
growing sense that the t i m e has come to be-
gin applying the lessons of the laboratory to 
disease. The in vitro findings of recent years 
have provided many insights in to cell-to-cell 
interactions. O n the other hand, i m m u n o l o -
gists haven't clarified the significance of 
most of these interactions i n the context of 
the real-world funct ioning of the i m m u n e 
system. 
"We've developed some very sophisticated 
model systems," says Dr. Beller, "and now 
we have to t r y to understand w h i c h of them 
can help explain what 's happening in 
vivo." • 
Suggested further reading 
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